A rating of 100 puts Avadel Pharmaceuticals PLC (AVDL) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Avadel Pharmaceuticals PLC's score of 100 means it scores higher than 100% of stocks in the industry. Avadel Pharmaceuticals PLC also received an overall rating of 90, putting it above 90% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 140 out of the 148 industries. AVDL has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on AVDL! See Full AVDL Report What do These Ratings Mean? Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest. What's Happening With Avadel Pharmaceuticals PLC Stock Today? Avadel Pharmaceuticals PLC (AVDL) stock is up 4.19% while the S&P 500 is down -0.54% as of 11:46 AM on Thursday, Oct 6. AVDL is up $0.24 from the previous closing price of $5.73 on volume of 608,631 shares. Over the past year the S&P 500 has fallen -13.77% while AVDL is down -38.45%. AVDL lost -$2.28 per share the over the last 12 months. Click Here to get the full Stock Report for Avadel Pharmaceuticals PLC stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy